Brief: Paion: Successful Completion Of Russian Remimazolam Phase III Clinical Trial By Partner R-Pharm

PAION AG

06/11/2018 11:12

Nov 6 (Reuters) - PAION AG  PA8G.DE :
    * ANNOUNCES SUCCESSFUL COMPLETION OF RUSSIAN REMIMAZOLAM
PHASE III
CLINICAL TRIAL BY PARTNER R-PHARM
    * TRIAL DATA FURTHER CONFIRMED HIGH SAFETY AND EFFICACY
PROFILE OF
REMIMAZOLAM
    * R-PHARM PLANS TO FILE FOR MARKETING AUTHORIZATION WITH
MINISTRY
OF HEALTHCARE OF RUSSIAN FEDERATION IN Q1 2019

Source text for Eikon:  ID:nEQ8sGZFGa 
Further company coverage:  PA8G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))